Artha Sootra - Company Dashboard

Governance Classic Home

Anthem Biosciences LtdBiotechnologyINE0CZ201020Consolidated₹887.45+32.95 (+3.86%)

Valuation

Market Cap₹50.05K Cr

TTM PE81.50x

Forward PE72.02x

PEG12.64

Book Value₹54.00

P/B16.45x

TTM EPS₹10.90

Fwd EPS₹12.33

TTM Revenue₹2.05K Cr

TTM PAT₹613.98 Cr

TTM EBITDA₹846.46 Cr

TTM EBIT₹711.64 Cr

Last Qtr PAT₹211.46 Cr

Last Qtr EBITDA₹271.49 Cr

Last Qtr EBIT₹240.78 Cr

Profitability

ROE20.18%

ROCE27.64%

TTM NPM30.00%

TTM EBITDA %41.36%

Curr OPM32.39%

Last OPM27.07%

Curr NPM—

Last NPM—

Curr EPS₹3.75

Last EPS₹2.13

Balance sheet

Equity₹112.34 Cr

Reserve₹2.93K Cr

Total Debt₹53.91 Cr

D/E0.02x

Interest %1.57%

Curr Interest₹3.31 Cr

Price / range

Close₹888.30

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+3.96%

1W+6.68%

1M+3.91%

3M+8.41%

6M+16.14%

1Y+26.45%

2Y—

3Y—

5Y—

Diwali+39.01%

Sector peers — Biotechnology

Company	Close	Mkt Cap	TTM P/E	ROE
ANTHEM	888.30	₹50.05K Cr	81.50	20.18%
ADVENZYMES	278.40	₹3.12K Cr	18.17	10.83%
GENESIS	35.93	₹162.58 Cr	-71.86	—
VIVOBIOT	13.88	₹30.68 Cr	5.69	—
SHREEGANES	0.44	₹17.54 Cr	—	—
GVBL	55.67	₹17.00 Cr	927.83	—

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	572.11+3.6%	383.84	582.50	416.58	552.23	2,089.31
Other Income	64.70	28.60	60.63	39.92	53.80	182.08
Total Income	636.80+5.1%	412.44	643.13	456.50	606.03	2,271.39
Interest	3.06	0.76	1.58	1.13	2.23	6.55
Expenditure	-332.69+5.7%	-276.08	-343.38	-281.40	-352.72	-1,344.31
PBDT	0	0	0	0	0	0
EBITDA	264.69+17.3%	130.83	266.98	163.06	225.66	851.12
Depreciation	-22.21	-22.31	-26.28	-26.75	-23.92	-99.57
EBIT	242.48+20.2%	108.52	240.70	136.31	201.74	751.55
PBT	304.12+20.1%	136.36	300.72	150.11	253.30	903.07
Tax	-83.23	-34.35	-89.06	-37.99	-54.87	-232.51
Equity	112.71	112.68	112.34	112.32	0	112.34
OPM	47.76	33.06	46.76	32.88	45.87	39.76
Net Profit	220.89+11.3%	102.01	211.66	112.12	198.43	670.56
NPM	34.69	24.73	32.91	24.56	35.93	29.52
EPS	3.92+10.7%	1.81	3.77	2	3.54	11.95

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26
Revenue	2,089.31
Other Income	182.08
Total Income	2,271.39
Expenditure	-1,344.31
Interest	-6.55
PBDT	0
EBITDA	851.12
Depreciation	-99.57
EBIT	751.55
PBT	903.07
Tax	-232.51
Equity	112.34
OPM (%)	39.76
Net Profit	670.56
NPM (%)	29.52
EPS (Rs)	11.95
CEPS	11.82

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	594.03+8.0%	418.22	610.94	423.15	550.03	2,124.33
Other Income	58.90	24.89	51.21	33.53	48.23	155.78
Total Income	652.93+9.1%	443.11	662.16	456.68	598.26	2,280.12
Interest	3.31	0.89	1.90	0.35	3.03	6.89
Expenditure	-356.56+3.3%	-298.53	-385.22	-300.84	-368.65	-1,431.49
PBDT	0	0	0	0	0	0
EBITDA	271.49+24.6%	150.57	267.21	157.19	217.91	833.80
Depreciation	-30.71	-29.99	-39.59	-34.53	-33.50	-134.07
EBIT	240.78+30.6%	120.58	227.62	122.66	184.41	699.73
PBT	296.37+29.1%	144.58	277.92	130.47	229.60	824.24
Tax	-84.91	-24.64	-88.16	-37.66	-56.17	-232.45
Equity	112.71	112.68	112.34	112.32	0	112.34
OPM	45.39	32.63	41.97	28.57	38.38	36.15
Net Profit	211.46+21.9%	119.94	189.76	92.82	173.43	591.79
NPM	32.39	27.07	28.66	20.32	28.99	25.95
EPS	3.75+21.4%	2.13	0	1.65	3.09	0

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26
Revenue	2,124.33
Other Income	155.78
Total Income	2,280.12
Expenditure	-1,431.49
Interest	-6.89
PBDT	0
EBITDA	833.80
Depreciation	-134.07
EBIT	699.73
PBT	824.24
Tax	-232.45
Equity	112.34
OPM (%)	36.15
Net Profit	591.79
NPM (%)	25.95
EPS (Rs)	0
CEPS	0

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	2	25 Jun 2026

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split